CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS - Concepedia

Concepedia

Publication | Closed Access

CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS

137

Citations

31

References

2007

Year

Michael A. Vogelbaum, John H. Sampson, Sandeep Kunwar, Susan M. Chang, Mark E. Shaffrey, Anthony L. Asher, Frederick F. Lang, David Croteau, Kristen Parker, Amy Grahn,

Abstract

CB (0.5 microg/mL) administered via convection-enhanced delivery before standard radiochemotherapy seems to be well tolerated in adults with newly diagnosed malignant gliomas. Further clinical study assessment is warranted.

References

	Year	Citations

Page 1